We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $118 · 2 analysts
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
Stored first · Google News · Yahoo Finance (English)
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares - Investing.com
Iradimed corp CEO Roger Susi sells $226,507 in IRMD shares Investing.com
IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan - Stock Titan
IRADIMED (IRMD) CEO-linked trust sells 2,500 shares under 10b5-1 plan Stock Titan
IRADIMED CEO Sells 7500 Common Stock Shares - asatunews.co.id
IRADIMED CEO Sells 7500 Common Stock Shares asatunews.co.id
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It - Yahoo Finance
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It Yahoo Finance
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
Iradimed Corp Quarterly Report Highlights Key Growth Drivers - Earnings Call Q&A - thelegaladvocate.com
Iradimed Corp Quarterly Report Highlights Key Growth Drivers - Earnings Call Q&A thelegaladvocate.com
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 07. 30. | After market close (AMC) | $0.44 | — | — | $20.35M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $0.37 | — | — | $19.51M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $1.1 | — | — | $53.85M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $0.71 | — | — | $35.53M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 04. 02. | Freedom Broker | — | Initiate coverage | — → Buy | — | Freedom Broker: Buy |
| 2025. 02. 15. | Roth MKM | — | Maintain | Buy → Buy | — | Roth MKM: Buy |
| 2024. 08. 03. | Roth MKM | — | Maintain | Buy → Buy | — | Roth MKM: Buy |
| 2021. 08. 02. | Roth Capital | — | Maintain | — → Buy | — | Roth Capital: Buy |
| 2017. 07. 31. | Roth Capital | — | Upgrade | Neutral → Buy | — | Roth Capital: Neutral → Buy |
| 2016. 10. 05. | Roth Capital | — | Downgrade | Buy → Neutral | — | Roth Capital: Buy → Neutral |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 165,669 | $15.95B | 0.01% | — | New position |
| 2 | TWO SIGMA INVESTMENTS, LP | TWO SIGMA INVESTMENTS, LP | 64,914 | $6.31B | 0.01% | — | New position |
| 3 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 14,319 | $1.38B | 0.00% | — | New position |
| 4 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 10,982 | $1.07B | 0.00% | — | New position |